Intravenous Infusions is trading at GHS 0.56, down -3.45%, against a backdrop of broader Ghana-market weakness; no company-specific announcement explaining the move was identified. - For the week to October 23, the GSE Composite Index fell 1.99%, and trading activity also declined. - Intravenous Infusions was among the week’s decliners; the weekly market move does not directly explain this session’s price change.